Effects of oestrogen on vulvovaginal candidosis
| Autor: | Yufei He, Jie Deng, Ruoyu Tang, Yongbing Cao, Ping He, Jianhua Wu, Tongkai Cai |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
medicine.drug_class
Physiology Dermatology Disease Pregnancy Candida albicans medicine Humans Hormone replacement therapy Candidiasis Vulvovaginal Candida biology business.industry Incidence (epidemiology) Incidence Estrogens General Medicine biology.organism_classification medicine.disease Infectious Diseases Multiple factors Infectious disease (medical specialty) Estrogen Female business |
| Zdroj: | MycosesREFERENCES. 65(1) |
| ISSN: | 1439-0507 |
| Popis: | As a frequently occurring infectious disease mainly caused by Candida albicans, vulvovaginal candidosis (VVC) affects more than 100 million women worldwide every year. Multiple factors that influence C. albicans colonisation have been linked to the incidence of VVC, including high levels of circulating oestrogen due to pregnancy, the use of oral contraceptives, and hormone replacement therapy. This review provides an overview of the current understanding of the mechanism(s) by which oestrogen contributes to VVC, which might provide meaningful guidance to the prevention and treatment of this disease. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text